Pilot study of (89)Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancer

BACKGROUND: The aim of this pilot study was to evaluate whether the uptake of (89)Zr-bevacizumab in non-small cell lung cancer (NSCLC) tumors could be visualized and quantified. The correlation between tumor (89)Zr-bevacizumab uptake and tumor response to antitumor therapy with a bevacizumab-based r...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahce, Idris, Huisman, Marc C, Verwer, Eline E, Ooijevaar, Rogier, Boutkourt, Firdaouss, Vugts, Danielle J, van Dongen, Guus AMS, Boellaard, Ronald, Smit, Egbert F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884046/
https://www.ncbi.nlm.nih.gov/pubmed/26055936
http://dx.doi.org/10.1186/s13550-014-0035-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884046/
https://www.ncbi.nlm.nih.gov/pubmed/26055936
http://dx.doi.org/10.1186/s13550-014-0035-5

Ejemplares similares